Incyte Announces Data on Ruxolitinib Cream in Atopic Dermatitis Accepted for Presentation at the Society for Investigative Dermatology (SID) Virtual Meeting 2021
Go back to Incyte Announces Data on Ruxolitinib Cream in Atopic Dermatitis Accepted for Presentation at the Society for Investigative Dermatology (SID) Virtual Meeting 2021| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 108.53 +0.70 (0.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $107.83 | 52 Week High | $118.49 | |||
| Open | $107.83 | 52 Week Low | $55.00 | |||
| Day High | $109.64 | P/E | N/A | |||
| Day Low | $106.53 | EPS | $-0.56 | |||
| Volume | 1,488,908 | |||||
